Accessibility Menu
Thc Farmaceuticals logo

Thc Farmaceuticals

(OTC) CBDG

Current Price$0.00
Market Cap$47.10K
Since IPO (2014)-100%
5 Year-99%
1 Year-70%
1 Month-86%

Thc Farmaceuticals Financials at a Glance

Market Cap

$47.10K

Revenue (TTM)

$15.03K

Net Income (TTM)

$48.13K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

44.45 (High)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.09

Estimated Earnings Date

N/A

CBDG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Farmaceuticals

Industry

Commercial Services and Supplies

Employees

2

CEO

Mark D. Grossman

Headquarters

Scottsdale, AZ 85253, US

CBDG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$47.10K

Shares Outstanding

18.13M

Volume

1.00K

Avg. Volume

940.188

Financials (TTM)

Gross Profit

-$4.95K

Operating Income

-$20.79K

EBITDA

-$15.84K

Operating Cash Flow

$635.54K

Capital Expenditure

$3.00

Free Cash Flow

$635.54K

Cash & ST Invst.

$0.00

Total Debt

$115.27K

Thc Farmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$952.00

-115.1%

Gross Margin

0.00%

N/A

Market Cap

$47.10K

N/A

Market Cap/Employee

$23.55K

N/A

Employees

2

N/A

Net Income

-$3.16K

+99.3%

EBITDA

-$5.37K

+99.4%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$6.87K

+237.7%

Total Debt

$386.30K

-57.9%

Accounts Receivable

$636.22K

+2.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$386.30K

-57.9%

Return on Assets

-0.38%

N/A

Return on Invested Capital

-0.77%

N/A

Free Cash Flow

-$4.48K

+90.4%

Operating Cash Flow

-$4.48K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PFNDPathfinder Cell Therapy, Inc.
$0.00+0.00%
RGBPRegen BioPharma, Inc.
$0.00+100.00%
IPIXInnovation Pharmaceuticals Inc.
$0.00-33.33%
WSNAFWesana Health Holdings Inc.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SMCISuper Micro Computer
$30.46-0.05%

Questions About CBDG

What is the current price of Thc Farmaceuticals?

Thc Farmaceuticals is trading at $0.00 per share.

What is the 52-week range for Thc Farmaceuticals?

Over the past 52 weeks, Thc Farmaceuticals has traded between $0.00 and $0.09.

How much debt does Thc Farmaceuticals have?

As of the most recent reporting period, Thc Farmaceuticals reported total debt of $115.27K.

How much cash does Thc Farmaceuticals have on hand?

Thc Farmaceuticals reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Thc Farmaceuticals’s dividend yield?

Thc Farmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.